• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Atlantic International Corp. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Financial Statements and Exhibits

    2/28/25 4:09:39 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $ATLN alert in real time by email
    false 0001605888 0001605888 2025-02-26 2025-02-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported) February 26, 2025

     

    ATLANTIC INTERNATIONAL CORP.

    (Exact name of registrant as specified in charter)

     

    Delaware   001-40760   46-5319744
    (State or other Jurisdiction of
    Incorporation or Organization)
      (Commission File Number)   (IRS Employer
    Identification No.)

     

    270 Sylvan Avenue, Suite 2230

    Englewood Cliffs, NJ

      07632
    (Address of Principal Executive Offices)   (zip code)

     

    (201) 899-4470

    (Registrant’s telephone number, including area code)

     

    NOT APPLICABLE

    (Former name or former address, if changed since last report)

     

    Securities registered or to be registered as pursuant to Section 12(b) of the Act: None

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

     

     

     

     

     

     

    Item 1.02 Termination of a Material Definitive Agreement

     

    On February 26, 2025, Atlantic International Corp. (“Atlantic,” or the “Company”) sent a notice of termination to Staffing 360 Solutions Inc. (“STAF”) pursuant to the terms and conditions of the Agreement and Plan of Merger by and among the Company, A36 Merger Sub, Inc. and STAF, dated as of November 1, 2024, as amended as of January 7, 2025 (the “M/A”). There was no material relationship between the Company and its affiliates and STAF other than in respect of the M/A. A copy of the M/A and of Amendment No. 1 to the M/A have been filed as exhibits with the SEC as set forth in Item 9.01 below and are incorporated herein by reference.

     

    Section 8.1(b) of the M/A, provides for termination in the event of a material breach by STAF of any covenant or agreement in the M/A which cannot be cured earlier than thirty (30) days after written notice or the March 31, 2025 Termination Date.

     

    Section 3.2(e) of the M/A required STAF to execute and/or deliver: “a signed agreement between the Internal Revenue Service and Company [i.e., STAF] concerning the terms of settlement mutually agreeable to Atlantic.” (Emphasis Added) Without the Company’s knowledge, STAF entered into agreements with the Internal Revenue Service that were not agreeable to Atlantic. STAF has materially failed to satisfy the terms of Section 3.2(e) and has done so in a manner that cannot be cured. Accordingly, pursuant to the above-stated Section 8.1(b), this was a material breach of the covenant and agreement set forth in Section 3.2(e) of the M/A to deliver: “a signed agreement between the Internal Revenue Service and Company [i.e., STAF] concerning the terms of settlement mutually agreeable to Atlantic.”

     

    Finally, STAF has failed to demonstrate compliance under 4.2 of the M/A, namely to (i) operate the Business in the ordinary course in all material respects and (ii) use commercially reasonable efforts to preserve intact the business organization, assets, properties and material business relations of the Company, both as reflected by STAF’s failure to satisfy its obligations and maintain its material business relations, among other reasons.

     

    There are no material termination penalties incurred by the Company.

     

    Item 9.01 Financial Statements and Exhibits

     

    (d) Exhibits

     

    Exhibit No.   Description
    2.1   Agreement and Plan of Merger by and among Atlantic International Corp., A36 Merger Sub Inc. and Staffing 360 Solutions, Inc. dated as of November 1, 2024 (incorporated by reference to the Issuer’s Current Report on Form 8-K filed with the SEC on November 7, 2024).
    2.2   First Amendment to Agreement and Plan of Merger dated as of January 7, 2025 (incorporated by reference to the Issuer’s Current Report on Form 8-K filed with the SEC on January 13, 2025).
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    1

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: February 28, 2025 ATLANTIC INTERNATIONAL CORP.
       
      By: /s/ Jeffrey Jagid
        Jeffrey Jagid
        Chief Executive Officer

     

    2

     

     

    Get the next $ATLN alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ATLN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ATLN
    SEC Filings

    See more
    • SEC Form RW filed by Atlantic International Corp.

      RW - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

      7/14/25 4:05:04 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form 424B3 filed by Atlantic International Corp.

      424B3 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

      7/8/25 4:31:45 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form EFFECT filed by Atlantic International Corp.

      EFFECT - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

      7/7/25 12:15:24 AM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ATLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Chief Financial Officer Broderick Christopher bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 40% to 2,004,237 units (SEC Form 4)

      4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      6/25/25 5:11:34 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Amendment: Chief Executive Officer Jagid Jeffrey M bought $289 worth of shares (2,885,856 units at $0.00), increasing direct ownership by 340% to 3,735,169 units (SEC Form 4)

      4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      6/25/25 5:04:40 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Amendment: General Counsel Tenore Michael bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 136% to 1,001,634 units (SEC Form 4)

      4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      6/25/25 5:02:59 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ATLN
    Financials

    Live finance-specific insights

    See more
    • Atlantic International Corp. Reports Strong 2024 Results with Over $442 Million in Revenue; Over 10% Revenue Growth

      Company Completes First Quarter Publicly-Traded on Nasdaq Global Market under "ATLN" Announces Strategic Developments and Outlook; Targets $1 to $1.5 Billion Revenue from Both Organic Growth and M&A Initiatives in the Next 12 to 18 Months ENGLEWOOD CLIFFS, N.J., March 28, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. ("Atlantic" or the "Company") (NASDAQ:ATLN), a leading provider of strategic staffing, outsourced services and workforce solutions, today announced its financial results for the fourth quarter and full year ended December 31, 2024. Key Financial Highlights: Q4 2024 Revenue: Revenue for the fourth quarter was $129.5 million, representing an 11.5% increase from $116.

      3/28/25 7:30:00 AM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ATLN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Chief Financial Officer Broderick Christopher bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 40% to 2,004,237 units (SEC Form 4)

      4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      6/25/25 5:11:34 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Amendment: Chief Executive Officer Jagid Jeffrey M bought $289 worth of shares (2,885,856 units at $0.00), increasing direct ownership by 340% to 3,735,169 units (SEC Form 4)

      4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      6/25/25 5:04:40 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Amendment: General Counsel Tenore Michael bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 136% to 1,001,634 units (SEC Form 4)

      4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      6/25/25 5:02:59 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ATLN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Atlantic International Corp. Postpones Annual General Meeting

      ENGLEWOOD CLIFFS, N.J., July 18, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a leading provider of strategic staffing, outsourced services, and workforce solutions, today announced that it has postponed its Annual General Meeting, originally scheduled for July 15, 2025, has been postponed until a date to be determined later this year. About Atlantic International Corp. Atlantic International Corp. (NASDAQ:ATLN) is a publicly traded global platform of outsourced services and workforce solutions. Through its subsidiaries, including Lyneer Staffing Solutions, Atlantic provides tailored staffing, recruiting, and strategic outsourcing solutions across a wide range

      7/18/25 5:30:00 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Atlantic International Corp. Added to Membership of Russell 3000® Index

      ENGLEWOOD CLIFFS, N.J., June 17, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a leading provider of strategic staffing, outsourced services, and workforce solutions, today announced that it has been added as a member of the broad-market Russell 3000® Index, effective after the U.S. market opens on June 30, 2025, as part of the 2025 Russell indexes annual reconstitution. The annual reconstitution of the Russell U.S. indexes captures the 4,000 largest U.S. stocks as of April 30, ranking them by total market capitalization. Membership in the Russell 3000® Index, which remains in place for one year, results in automatic inclusion in either the large-cap Russell 100

      6/17/25 9:01:17 AM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Lyneer Staffing Solutions Integrates Advanced AI Capabilities into Proprietary Ecosystem, Advancing Data-Driven Workforce Solutions

      ENGLEWOOD CLIFFS, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. ("Atlantic") (NASDAQ:ATLN), a leading provider of strategic staffing, outsourced services, and workforce solutions, today announced that its subsidiary Lyneer Staffing Solutions ("Lyneer") has successfully integrated cutting-edge artificial intelligence capabilities into its proprietary Apollo Ecosystem. This strategic enhancement positions Lyneer at the forefront of the staffing industry's digital transformation while maintaining its commitment to human-centered service delivery. The AI-powered Apollo Ecosystem now leverages advanced machine learning algorithms and predictive analytics to deliver unp

      6/5/25 12:00:00 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ATLN
    Leadership Updates

    Live Leadership Updates

    See more
    • Atlantic International Corp. Appoints Industry Veteran Matt Evelt as Chief Operating Officer to Lead Global Workforce Solutions Strategy

      ENGLEWOOD CLIFFS, N.J., June 02, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a premier provider of outsourced services, staffing, and workforce solutions, today announced the appointment of Matt Evelt as Chief Operating Officer (COO), effective immediately. Evelt brings more than two decades of leadership experience in workforce strategy, operational transformation, and international expansion. In his new role, he will oversee global operations, drive efficiency, and help scale Atlantic International's delivery of innovative, client-focused staffing and workforce solutions. Evelt most recently served as President – Americas at Airswift, where he successfully led

      6/2/25 1:05:49 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials